Table 2.
Participant | Subtype | Sample | ART line | Viral load (copies/mL) | pol drug resistance mutations (consensus sequence) | Integrase L74I (%) | Integrase L74I evolution |
---|---|---|---|---|---|---|---|
1 | G | 1 | first | 373 000 | RT: M184V, K103N, Y318F | 99.2 | fixed majority |
2 | first | 274 500 | RT: K70R, M184V, K219Q, K103N, Y318F | 88.4 | |||
2 | G | 1 | first | 532 000 | RT: D67N, K70R, M184V, T215I, K219E, Y181C | 99.6 | fixed majority |
2 | second | 36 000 | RT: M184V, T215F, K219E, V179VLM, Y181C | 90.9 | |||
3 | G | 1 | first | 29 000 | RT: K70R, M184V, A98G, V108I, Y181C | 95.6 | fixed majority |
2 | second | 4300 | RT: K70R, M184V, T215F, K219Q, V108I, Y181C, N348I | 93.3 | |||
4 | G | 1 | first | 25 000 | RT: M184V, K103N, K238T | 99.5 | fixed majority |
2 | second | 1 450 000 | none | 99.8 | |||
5 | G | 1 | first | 370 000 | RT: M184V, K103N, Y318F | 99.2 | fixed majority |
2 | second | 275 000 | RT: K70R, M184V, K219Q, K103N, Y318F | 88.4 | |||
6 | G | 1 | first | 28 000 | RT: M41L, D67N, T69D, K70R, V75M, M184V, T215F, K219Q, A98G, K103N, V179E, K238T, Y318F | 85.5 | fixed majority |
2 | first | 63 000 | RT: M41L, D67N, T69D, K70R, V75M, M184V, T215F, K219Q, A98G, K103N, V179E, K238T, Y318F | 99.1 | |||
3 | first | 442 000 | RT: M41L, D67N, T69D, K70R, V75M, M184V, T215FL, K219Q, A98G, K103N, V179E, K238T, Y318F | 98.9 | |||
4 | second | 5800 | RT: M41L, D67N, T69D, V75M, M184V, T215IV, K219Q, A98G, K103N, V179E, K238T, Y318F | 97.7 | |||
7 | AG | 1 | first | 48 000 | RT: M184V, K103N, P225H | 98.1 | fixed majority |
2 | second | 11 000 | RT: M184V, K103N | 94.7 | |||
8 | AG | 1 | first | 241 000 | RT: K103N, H221Y | 99.5 | fixed majority |
2 | first | 250 000 | RT: Y181C, H221Y | 99.0 | |||
3 | second | 4400 | RT: K103N, Y181C, H221Y | 92.3 | |||
9 | G | 1 | first | 272 000 | RT: K70E, Y115F, M184V, Y181C, G190A, H221Y | 90.0 | revertant majority |
2 | second | 24 000 | RT: K70E, Y115F, M184V, Y181C, G190A, H221YPro: M46I, I54V, V82S, L24I, L33F | ND | |||
10 | G | 1 | first | 59 000 | RT: K65R, M184V, K219E, Y181C, H221Y | 2.2 | fixed minority |
2 | second | 1700 | RT: K65R, M184V, K219E, Y181C, H221YPro: I54V, V82A, L10F | 2.7 | |||
11 | G | 1 | second | 5700 | RT: M41L, V75I, M184V, T215F, K101H, G190A, N348I | 3.6 | fixed minority |
2 | second | 384 000 | RT: M41L, D67N, V75I, M184V, T215F, G190A, N348I | 2.1 | |||
12 | AG | 1 | second | 5700 | RT: M41L, V75I, M184V, T215F, K101H, G190A, N348I | 3.6 | fixed minority |
2 | second | 384 000 | RT: M41L, D67N, V75I, T215F, G190A, N348I | 2.1 | |||
13 | G | 1 | first | 20 000 | RT: M184V, K101E, G190A | ND | emergent minority |
2 | second | 118 000 | none | 8.1 | |||
14 | G | 1 | first | 77 000 | RT: M41L, E44D, D67N, K70R, L74V, M184V, T215Y, Y181C, G190A, N348IPro: L90M | 39.2 | revertant minority |
2 | second | 56 000 | RT: M41L, E44D, D67N, T69D, K70R, L74V, M184V, T215Y, Y181C, G190A, N348IPro: M46I, 154V, V82A, L90M | 2.4 |
RT, reverse transcriptase; Pro, protease; AG, CRF02_AG; ND, not detected.